ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

NuggMD Launches Patient Choice Awards for Cannabis Brands, Products, and Technology

New York City (Newsworthy.ai) Friday Feb 7, 2025 @ 1:15 PM Eastern —

Cannabis brands have a new platform on which to promote their products and obtain valuable feedback from their customers in the NuggMD Patient Choice Awards, a new, consumer-driven awards program announced today by the country’s leading telehealth platform for cannabis.

The 2025 Patient Choice Awards will take place digitally. Cannabis consumers will cast votes across five categories: cannabis products, cannabis brands, cannabis dispensaries, cannabis technology, and cannabis creators. NuggMD will validate those votes to ensure integrity and accuracy.

Voting will take place from Feb. 25 to March 31, and the winners will be recognized by NuggMD and its affiliates on April 11.

NuggMD’s representative sample of 1.2m frequent cannabis consumers, which it uses to conduct the NuggMD Cannabis Consumer Poll, will be one primary channel used to drive consumer participation in the awards. Brands that wish to compete can activate their audiences however they wish. The winners will receive recognition and other promotional assets.

“The worn-out stereotypes of cannabis consumers are no longer anywhere close to the reality on the ground. One of the more important trends we’re seeing in our polling is that most people who use cannabis today do so for wellness, not indulgence. They are also much more likely to trust a friend’s product recommendation over a brand’s or budtender’s. It’s time to give patients a real voice in establishing which brands and products serve them the best,” said Robert Brock, VP of marketing, NuggMD.

For more information, to register to vote, or to nominate a brand, please visit the NuggMD Patient Choice Awards website.

About NuggMD

NuggMD is the nation’s leading medical marijuana technology platform, serving patients in Arizona, California, Connecticut, Delaware, Florida, Georgia, Illinois, Iowa, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Missouri, Montana, Nevada, New Jersey, New Mexico, New York, Ohio, Oklahoma, Pennsylvania, Texas, Vermont, Virginia, Washington, and West Virginia. They’ve connected over 2,000,000 patients face-to-face with their new medical marijuana doctors via their state-of-the-art telemedicine platform. They believe every human being has the right to explore the potential benefits of medical cannabis and are fully committed to helping each patient explore every option in their journey to wellness. For further information, visit https://www.nuggmd.com.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform.™

The reference URL for this press release is located here NuggMD Launches Patient Choice Awards for Cannabis Brands, Products, and Technology.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.